Advisory Committee on Immunization Practices (ACIP); Cancellation of Meeting, 35093-35094 [2021-14007]

Download as PDF Federal Register / Vol. 86, No. 124 / Thursday, July 1, 2021 / Notices Board, if any, are available for immediate inspection at the Federal Reserve Bank(s) indicated below and at the offices of the Board of Governors. This information may also be obtained on an expedited basis, upon request, by contacting the appropriate Federal Reserve Bank and from the Board’s Freedom of Information Office at https://www.federalreserve.gov/foia/ request.htm. Interested persons may express their views in writing on the standards enumerated in paragraph 7 of the Act. Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551–0001, not later than July 16, 2021. A. Federal Reserve Bank of St. Louis (Holly A. Rieser, Manager) P.O. Box 442, St. Louis, Missouri 63166–2034. Comments can also be sent electronically to Comments.applications@stls.frb.org: 1. Steuart L. Walton, Thomas L. Walton, Alice A. Proietti, and James M. Walton, all of Bentonville, Arkansas; to become members of the Walton Family Group, a group acting in concert to retain voting shares of Arvest Bank Group, Inc., Bentonville, Arkansas, and thereby indirectly retain voting shares of Arvest Bank, Fayetteville, Arkansas. Board of Governors of the Federal Reserve System, June 28, 2021. Michele Taylor Fennell, Deputy Associate Secretary of the Board. [FR Doc. 2021–14126 Filed 6–30–21; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Meeting of the National Advisory Council for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of public meeting. AGENCY: This notice announces a meeting of the National Advisory Council for Healthcare Research and Quality. khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: The meeting will be held on Wednesday, July 14, 2021, from 10:00 a.m. to 2:30 p.m. ADDRESSES: The meeting will be held virtually. DATES: VerDate Sep<11>2014 16:45 Jun 30, 2021 Jkt 253001 FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management Official, at the Agency for Healthcare Research and Quality, 5600 Fishers Lane, Mail Stop 06E37A, Rockville, Maryland 20857, (301) 427– 1456. For press-related information, please contact Bruce Seeman at (301) 427–1998 or Bruce.Seeman@ AHRQ.hhs.gov. Closed captioning will be provided during the meeting. If another reasonable accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827–4840, no later than Friday, July 2, 2021. The agenda, roster, and minutes will be available from Ms. Heather Phelps, Committee Management Officer, Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, Maryland 20857. Ms. Phelps’ phone number is (301) 427–1128. SUPPLEMENTARY INFORMATION: I. Purpose In accordance with section 10(a) of the Federal Advisory Committee Act, 5 U.S.C. App., this notice announces a meeting of the National Advisory Council for Healthcare Research and Quality (the Council). The Council is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. II. Agenda On Wednesday, July 14, 2021, the Council meeting will convene at 10:00 a.m., with the call to order by the Council Chair and approval of previous Council summary notes. The meeting will begin with an update on AHRQ’s recent accomplishments in Health Systems Research, Practice Improvement, and Data and Analytics. The agenda will also include discussions on Strategic Opportunities for FY22, Opportunities to Advance PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 35093 Telehealth and Advancing Patient Safety. The meeting will adjourn at 2:30 p.m. The meeting is open to the public. For information regarding how to access the meeting as well as other meeting details, including information on how to make a public comment, please go to https://www.ahrq.gov/news/events/nac/. The final agenda will be available on the AHRQ website no later than Wednesday, July 7, 2021. Dated: June 25, 2021. Marquita Cullom, Associate Director. [FR Doc. 2021–14010 Filed 6–30–21; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2021–0060] Advisory Committee on Immunization Practices (ACIP); Cancellation of Meeting Notice is hereby given of a change in the meeting of the Advisory Committee on Immunization Practices (ACIP); June 18, 2021, 11:00 a.m. to 5:00 p.m., EDT (dates and times subject to change), in the original FRN. The virtual meeting was published in the Federal Register on June 15, 2021, Volume 86, Number 113, pages 31716– 31717. Due to the Federal holiday on June 18, 2021, the ACIP meeting has been canceled in its entirety. In addition, the previously scheduled June 18, 2021 agenda items will be discussed at the ACIP meeting on June 23–25, 2021. Additionally, public comments submitted to docket number CDC–2021– 0060 will be shared with ACIP members at or prior to the June 23–25, 2021 meeting. FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee Management Specialist, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road NE, MS–H24–8, Atlanta, Georgia 30329– 4027; Telephone: (404) 639–8367; Email: ACIP@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and E:\FR\FM\01JYN1.SGM 01JYN1 35094 Federal Register / Vol. 86, No. 124 / Thursday, July 1, 2021 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–14007 Filed 6–30–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) Meeting Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Healthcare Infection Control Practices Advisory Committee (HICPAC). This virtual meeting is open to the public, limited only by audio and web conference lines (300 audio and web conference lines are available). Registration is required. To register for this web conference, please go to: www.cdc.gov/hicpac. All registered participants will receive the meeting link and instructions shortly before the meeting. DATES: The meeting will be held on August 19, 2021, from 12:00 p.m. to 2:00 p.m., EDT. ADDRESSES: Please click the link below to join the webinar: https:// cdc.zoomgov.com/j/1612908106? pwd=M0xTVWxmUTRtZXhu OVBzWmsybFZxZz09. Meeting ID: 161 290 8106 Passcode: yq!BLL44 Dial-in Lines: +1–669–254–5252 (San Jose) +1–646–828–7666 (New York) Meeting ID: 161 290 8106 Telephone Passcode: 47632330. FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, Mailstop H16–3, Atlanta, Georgia 30329–4027; Telephone: (404) 498–0730; Email: HICPAC@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion (DHQP), the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:45 Jun 30, 2021 Jkt 253001 the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters To Be Considered: The agenda will include the following updates: The Healthcare Personnel Guideline Workgroup; the Isolation Precautions Guideline Workgroup; and the Neonatal Intensive Care Unit Workgroup. Agenda items are subject to change as priorities dictate. Procedures for Public Comment: Time will be available for public comment. Members of the public who wish to provide public comments should plan to attend the public comment session at the start time listed. Please note that the public comment period may end before the time indicated, following the last call for comments. Procedures for Written Comment: The public may submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed above. The deadline for receipt of written public comment is July 26, 2021. All requests must contain the name, address, and organizational affiliation of the speaker, as well as the topic being addressed. Written comments should not exceed one single-spaced typed page in length. Written comments received in advance of the meeting will be included in the official record of the meeting. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–14008 Filed 6–30–21; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10516] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. SUMMARY: Comments on the collection(s) of information must be received by the OMB desk officer by August 2, 2021. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following: 1. Access CMS’ website address at: https://www.cms.gov/Regulations-andGuidance/Legislation/Paperwork ReductionActof1995/PRA-Listing.html FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786–4669. DATES: E:\FR\FM\01JYN1.SGM 01JYN1

Agencies

[Federal Register Volume 86, Number 124 (Thursday, July 1, 2021)]
[Notices]
[Pages 35093-35094]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14007]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2021-0060]


Advisory Committee on Immunization Practices (ACIP); Cancellation 
of Meeting

    Notice is hereby given of a change in the meeting of the Advisory 
Committee on Immunization Practices (ACIP); June 18, 2021, 11:00 a.m. 
to 5:00 p.m., EDT (dates and times subject to change), in the original 
FRN.
    The virtual meeting was published in the Federal Register on June 
15, 2021, Volume 86, Number 113, pages 31716-31717.
    Due to the Federal holiday on June 18, 2021, the ACIP meeting has 
been canceled in its entirety. In addition, the previously scheduled 
June 18, 2021 agenda items will be discussed at the ACIP meeting on 
June 23-25, 2021. Additionally, public comments submitted to docket 
number CDC-2021-0060 will be shared with ACIP members at or prior to 
the June 23-25, 2021 meeting.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, Centers for Disease Control and Prevention, 
National Center for Immunization and Respiratory Diseases, 1600 Clifton 
Road NE, MS-H24-8, Atlanta, Georgia 30329-4027; Telephone: (404) 639-
8367; Email: [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and

[[Page 35094]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-14007 Filed 6-30-21; 8:45 am]
BILLING CODE 4163-18-P